BETTER THERAPEUTICS Stock Price, News & Analysis

BTTX OTC Link

Company Description

Welcome to the overview page for BETTER THERAPEUTICS (BTTX), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-50%

Performance 1 year

$5.5K

Market Cap

49.9M

Shares outstanding

Latest News

View All

March 14, 2024

-82.84%

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

March 5, 2024

-7.26%

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

partnership

March 4, 2024

+5.78%

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

March 1, 2024

+15.63%

Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

February 20, 2024

-22.38%

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

fda approval

February 6, 2024

-10.16%

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

SEC Filings

View All

No SEC filings available for BETTER THERAPEUTICS.

Financial Highlights

View Full Financials

-$39.8M

Net Income (TTM)

$-1.69

Diluted EPS (TTM)

-$28.9M

Operating Cash Flow

1.37

Current Ratio

-$38.3M

Operating Income

—

Revenue (TTM)

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Short interest in BETTER THERAPEUTICS (BTTX) currently stands at 1.0 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Loading days to cover data...

Days to cover for BETTER THERAPEUTICS (BTTX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 8.6 days.

Frequently Asked Questions

What is the current stock price of BETTER THERAPEUTICS (BTTX)?

The current stock price of BETTER THERAPEUTICS (BTTX) is $0.0001 as of February 19, 2026.

What is the market cap of BETTER THERAPEUTICS (BTTX)?

The market cap of BETTER THERAPEUTICS (BTTX) is approximately 5.5K. Learn more about what market capitalization means .

What is the net income of BETTER THERAPEUTICS (BTTX)?

The trailing twelve months (TTM) net income of BETTER THERAPEUTICS (BTTX) is -$39.8M.

What is the earnings per share (EPS) of BETTER THERAPEUTICS (BTTX)?

The diluted earnings per share (EPS) of BETTER THERAPEUTICS (BTTX) is $-1.69 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of BETTER THERAPEUTICS (BTTX)?

The operating cash flow of BETTER THERAPEUTICS (BTTX) is -$28.9M. Learn about cash flow.

What is the current ratio of BETTER THERAPEUTICS (BTTX)?

The current ratio of BETTER THERAPEUTICS (BTTX) is 1.37, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of BETTER THERAPEUTICS (BTTX)?

The operating income of BETTER THERAPEUTICS (BTTX) is -$38.3M. Learn about operating income.